dts

DTS is a selective and isoform-specific RSK1 kinase inhibitor. It also has broad cancer therapeutic potential.

DTS-108 是 SN38 (一种拓扑异构酶 I抑制剂) 的前药。作为一种偶联物，DTS-108 通过酯酶敏感的交联剂将 SN38 与人类寡肽相连接。DTS-108 展现出对结直肠癌、肺癌和乳腺癌的抗癌活性。

DTS-201 sodium (CPI-0004Na) 是一种Doxorubicin的肽前药。DTS-201 含有四肽结构，能在肿瘤环境中被内肽酶水解，从而释放出代谢物，并在进入细胞后转化为活性的Doxorubicin。在前列腺癌、乳腺癌和肺癌的肿瘤异种移植模型中，DTS-201 表现出抗肿瘤活性。

DTSSP Crosslinker 是一种可降解的 ADC linker，可用于合成抗体-药物偶联物 (ADCs)。

FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].

FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, which can be accurately assessed using selected reaction monitoring (SRM).

Activated T Subunit 用于合成可诱导外显子51跳跃的外显子跳跃寡聚物偶联物。该寡聚物偶联物与人类抗肌萎缩蛋白基因中选定靶位点互补，适用于肌肉萎缩症研究。